Hematologia Geral
Estudo mostra risco aumentado de embolia pulmonar em até 110 dias após a COVID-19.
8 Abr, 2022 | 21:58hComunicado de imprensa: Study finds increased risk of serious blood clots up to six months after COVID-19 – BMJ
Editorial: Thromboembolism and bleeding after covid-19
Comentário: Covid: Blood clot risk higher for six months after having virus – BBC
M-A | Risco de recorrência em mulheres com tromboembolismo venoso relacionado ao uso de contraceptivos com estrogênio.
8 Abr, 2022 | 17:28hEstudo randomizado | Eritropoietina não é benéfica para pacientes com lesão renal aguda.
8 Abr, 2022 | 17:02hErythropoietin in Acute Kidney Injury (EAKI): a pragmatic randomized clinical trial – BMC Nephrology
Revisão prática | Tratamento efetivo e baseado em evidências para a anemia em pacientes sob cuidados paliativos.
1 Abr, 2022 | 12:44hEstudo randomizado | Tratamento precoce de pacientes ambulatoriais com plasma convalescente reduz o risco de internação para pacientes com Covid-19.
1 Abr, 2022 | 12:30hEarly Outpatient Treatment for Covid-19 with Convalescent Plasma – New England Journal of Medicine
Comentários:
Early Use of High-Titer Plasma Reduced COVID Hospitalizations— Randomized trial that influenced indication shows benefits in a mostly unvaccinated population – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Fewer recipients of convalescent plasma had progression of Covid-19–associated illness leading to hospitalization. https://t.co/joa9ajpAcd pic.twitter.com/mHTnEHYN2O
— NEJM (@NEJM) March 30, 2022
Estudo de coorte retrospectiva | Riscos de anafilaxia com formulações intravenosas de ferro.
31 Mar, 2022 | 13:19hRisks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University
Comentário: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay
Consenso multidisciplinar para o tratamento do tromboembolismo pulmonar.
29 Mar, 2022 | 14:59hRecomendações de consenso | Tratamento da trombocitopenia imune.
29 Mar, 2022 | 14:56hEstudo randomizado | Efeitos da transfusão de hemácias recém-irradiadas vs. irradiadas e armazenadas sobre a oxigenação cerebral de prematuros.
29 Mar, 2022 | 14:50hEffects of Freshly Irradiated vs Irradiated and Stored Red Blood Cell Transfusion on Cerebral Oxygenation in Preterm Infants: A Randomized Clinical Trial – JAMA Pediatrics (gratuito por tempo limitado)
Editorial: Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation – JAMA Pediatrics (gratuito por tempo limitado)
Comentário no Twitter
In a proof-of-concept randomized trial, transfusion of freshly irradiated red blood cells resulted in favorable cerebral oxygenation kinetics in preterm infants compared with transfusion of irradiated and stored red blood cells. https://t.co/IqpyhKuv9z pic.twitter.com/BzTNnkgzm7
— JAMA Pediatrics (@JAMAPediatrics) March 28, 2022
Estudo randomizado | Entre pacientes críticos com Covid-19, o tratamento com um agente antiplaquetário teve pouca propensão a melhorar os dias sem suporte de órgão em 21 dias.
24 Mar, 2022 | 12:33hEditorial: Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status – JAMA
Comentário: Aspirin may improve 3-month survival for patients critically ill with COVID-19 – Imperial College London
Comentários no Twitter
In this bayesian randomized clinical trial, among critically ill patients with #COVID19, there was a low likelihood that treatment with an antiplatelet agent provided improvement in organ support–free days within 21 days. https://t.co/CnyWoOTn3Q
— JAMA (@JAMA_current) March 22, 2022